BIM DELETION POLYMORPHISMS IN COLOMBIAN PATIENTS WITH NON-SMALL CELL LUNG CANCER WHO CARRIERS EGFR MUTATIONS (CLICAP)

被引：0
作者：
Cardona Cardona, Andres Felipe [1 ]
Arrieta, Oscar [2 ]
Karachaliou, Niki [3 ]
Drozdowskyj, Ana [3 ]
Gimenez Capitan, Ana [4 ]
Angel Molina, Miguel [4 ]
Martin, Claudio [5 ]
Carranza, Hernan [1 ]
Vargas, Carlos [1 ]
Otero, Jorge [1 ]
Rojas, Leonardo [6 ]
Cuello, Mauricio [7 ]
Rosell, Rafael [4 ]
机构：
[1] Fdn Santa Fe Bogota, Inst Oncol, Bogota, Colombia
[2] Inst Nacl Cancerol, Expt Oncolgy Lab, Mexico City, DF, Mexico
[3] Pangaea Biotech, Barcelona, Spain
[4] Hosp Badalona Germans Trias & Pujol, Inst Catalan Oncol, Barcelona, Spain
[5] Inst Fleming, Buenos Aires, DF, Argentina
[6] Hosp Univ San Ignacio, Ctr Javeriano Oncol, Bogota, Colombia
[7] Hosp Clin Udelar, Montevideo, Uruguay
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 09期
关键词：
BIM deletion; Non-small-cell lung cancer; EGFR-mutations;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.38
引用
收藏
页码：S174 / S174
页数：1
相关论文
共 50 条
  • [31] Prevalence and Patterns of EGFR Mutations in Non-small Cell Lung Cancer in the Middle East and North Africa
    Boustany, Youssra
    Laraqui, Abdelilah
    El Rhaffouli, Hicham
    Bajjou, Tahar
    El Mchichi, Bouchra
    El Anaz, Hicham
    Amine, Idriss Lahlou
    Chahdi, Hafsa
    Oukabli, Mohammed
    Souhi, Hicham
    Elouazzani, Hanane
    Rhorfi, Ismail Abderrahmani
    Abid, Ahmed
    Mahfoud, Tarik
    Tanz, Rachid
    Ichou, Mohammed
    Ennibi, Khaled
    Belkadi, Bouchra
    Sekhsokh, Yassine
    CANCER CONTROL, 2022, 29
  • [32] Tissue or blood: which is more suitable for detection of EGFR mutations in non-small cell lung cancer?
    Rong Biaoxue
    Yang Shuanying
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2018, 33 (01) : 40 - 48
  • [33] The prevalence of EGFR mutations in non-small cell lung cancer in an unselected Caucasian population
    Skov, Birgit G.
    Hogdall, Estrid
    Clementsen, Paul
    Krasnik, Mark
    Larsen, Klaus Richter
    Sorensen, Jens Benn
    Skov, Torsten
    Mellemgaard, Anders
    APMIS, 2015, 123 (02) : 108 - 115
  • [34] EGFR mutations in patients with non small-cell lung cancer in Bulgaria and treatment with gefitinib
    Damyanov, Danail
    Koynov, Krassimir
    Naseva, Emilia
    Bichev, Stoyan
    JOURNAL OF BUON, 2015, 20 (01): : 136 - 141
  • [35] The Predictive Values of Non-Resistant Nncommon EGFR Mutations in Advanced Non-Small Cell Lung Cancer Patients
    Deng, P.
    Tan, J.
    Hu, C.
    Cao, L.
    Yang, H.
    Li, M.
    Gu, Q.
    Li, Y.
    An, J.
    Han-Zhang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S594 - S595
  • [36] EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer
    Syrigos, K.
    Tsagouli, S.
    Gkiozos, I.
    Paraskeva, M.
    Kotteas, I.
    Tsimpoukis, S.
    Zontanos, M.
    Grapsa, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S903 - S903
  • [37] Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations
    Mizoguchi, Kosuke
    Nakamura, Yoichi
    Sano, Kazumi
    Sato, Shuntaro
    Ikegami, Yoji
    Motoshima, Kohei
    Takemoto, Shinnosuke
    Ogawara, Daiki
    Senju, Hiroaki
    Sugasaki, Nanae
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Fukuda, Minoru
    Izumikawa, Koichi
    Mukae, Hiroshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (02) : 377 - 382
  • [38] EGFR activating mutations and their association with response to platinum-doublet chemotherapy in Brazilian non-small cell lung cancer patients
    Helen N. Honma
    Maurício W. Perroud
    Maurício S. T. Leme
    Aristóteles S. Barbeiro
    Bruna A. Saad
    André M. Morcillo
    José Vassallo
    Daniel B. Costa
    Lair Zambon
    Targeted Oncology, 2014, 9 : 389 - 394
  • [39] Treatment with EGFR-TKIs in Non Small Cell Lung Cancer Patients. The Impact of EGFR Mutations
    Garcia Manrique, Teresa
    Carrillo De Albornoz, Rosario
    Milena Vargas, Ana
    Alamo De la Gala, M. Carmen
    Grueso Lopez, Ana Maria
    Barros Perez, M. Mar
    Vicente Baz, David
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S408 - S408
  • [40] EGFR activating mutations and their association with response to platinum-doublet chemotherapy in Brazilian non-small cell lung cancer patients
    Honma, Helen N.
    Perroud, Mauricio W., Jr.
    Leme, Mauricio S. T.
    Barbeiro, Aristoteles S.
    Saad, Bruna A.
    Morcillo, Andre M.
    Vassallo, Jose
    Costa, Daniel B.
    Zambon, Lair
    TARGETED ONCOLOGY, 2014, 9 (04) : 389 - 394
12345